Article
Inhibition of monocarboxylate transporter 2 induces senescence-associated mitochondrial dysfunction and suppresses progression of colorectal malignancies in vivo.
Molecular cancer therapeutics - 1 Nov 2012
Lee Inkyoung, Lee Sook-Ja, Kang Won Ki, Park Chaehwa
Abstract excerpt
Senescence, an inherent tumor suppressive mechanism, is a critical determinant for chemotherapy. In the present study, we show that the monocarboxylate transporter 2 (MCT2) protein was tumor-selectively expressed in human colorectal malignancies and knockdown of MCT2 induces mitochondrial dysfunc...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
